Antimicrobial activities of piperacillin-tazobactam against Haemophilus influenzae isolates, including β-lactamase-negative ampicillin-resistant and β-lactamase-positive amoxicillin-clavulanate-resistant isolates, and mutations in their quinolone resistance-determining regions

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 10, 2009, Pages 4225-4230

  Hirakata, Yoichi ^a   Ohmori, Kaori ^b   Mikuriya, Miwako ^b   Saika, Takeshi ^b   Matsuzaki, Kaoru ^b   Hasegawa, Miyuki ^b   Hatta, Masumitsu ^a   Yamamoto, Natsuo ^a   Kunishima, Hiroyuki ^a   Yano, Hisakazu ^a   Kitagawa, Miho ^a   Arai, Kazuaki ^a   Kawakami, Kazuyoshi ^a   Kobayashi, Intetsu ^c   Jones, Ronald N ^d   Kohno, Shigeru ^e   Yamaguchi, Keizo ^f   Kaku, Mitsuo ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b LSI MEDIENCE CORPORATION   (Japan)

^c TOHO UNIVERSITY   (Japan)

^d JMI LABORATORIES   (United States)

^e NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; BACTERIAL DNA; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CEFTRIAXONE; CIPROFLOXACIN; DNA FRAGMENT; IMIPENEM; MEROPENEM; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; PRIMER DNA; QUINOLONE; SULTAMICILLIN;

AMINO ACID SUBSTITUTION; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL MUTATION; BACTERIUM ISOLATE; BROTH DILUTION; CONTROLLED STUDY; DISK DIFFUSION; DNA SEQUENCE; DRUG POTENCY; HAEMOPHILUS INFLUENZAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION;

AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; AMPICILLIN; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CIPROFLOXACIN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HAEMOPHILUS INFLUENZAE; MICROBIAL SENSITIVITY TESTS; MUTATION;

EID: 70349342840     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00192-09     Document Type: Article

References (33)

1. Biedenbach, D. J., and R. N. Jones. 2003. Five-year analysis of Haemophilus influenzae isolates with reduced susceptibility to fluoroquinolones: prevalence results from the SENTRY antimicrobial surveillance program. Diagn. Microbiol. Infect. Dis. 46:55-61.
2. Clairoux, N., M. Picard, A. Brochu, N. Rousseau, P. Gourde, D. Beauchamp, T. R. Parr, Jr., M. G. Bergeron, and F. Malouin. 1992. Molecular basis of non-β-lactamase-mediated resistance to β-lactam antibiotics in strains of Haemophilus influenzae. Antimicrob. Agents Chemother. 36:1504-1513.
3. Clinical and Laboratory Standards Institute. 2006. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, M7-A7. Approved standard, 7th ed. Clinical and Laboratory Standards Institute, Wayne, PA.
4. Clinical and Laboratory Standards Institute. 2006. Performance standards for antimicrobial disk susceptibility tests, M2-A9. Approved standard, 9th ed. Clinical and Laboratory Standards Institute, Wayne, PA.
5. Clinical and Laboratory Standards Institute. 2007. Performance standards for antimicrobial susceptibility testing, 15th edition. Approved standard M100-S17. Clinical and Laboratory Standards Institute, Wayne, PA.
6. Dabernat, H., C. Delmas, M. Seguy, R. Pelisser, G. Faucon, S. Bennamani, and C. Pasquier. 2002. Diversity of β-lactam resistance-conferring amino acid substitutions in penicillin-binding protein 3 of Haemophilus influenzae. Antimicrob. Agents Chemother. 46:2208-2218. (Pubitemid 34665918)
7. Davies, T. A., L. M. Kelly, D. B. Hoellman, L. M. Ednie, C. L. Clark, S. Bajaksouzian, M. R. Jacobs, and P. C. Appelbaum. 2000. Activities and postantibiotic effects of gemifloxacin compared to those of 11 other agents against Haemophilus influenzae and Moraxella catarrhalis. Antimicrob. Agents Chemother. 44:633-639. (Pubitemid 30117953)
8. Doern, G. V., A. B. Brueggemann, G. Pierce, H. P. Holley, Jr., and A. Rauch. 1997. Antibiotic resistance among clinical isolates of Haemophilus influenzae in the United States in 1994 and 1995 and detection of β-lactamase-positive strains resistant to amoxicillin-clavulanate: results of a national multicenter surveillance study. Antimicrob. Agents Chemother. 41:292-297.
9. Fukushima, K. Y., Y. Hirakata, K. Sugahara, K. Yanagihara, A. Kondo, S. Kohno, and S. Kamihira. 2006. Rapid screening of topoisomerase gene mutations by a novel melting curve analysis method for early warning of fluoroquinolone- resistant Streptococcus pneumoniae emergence. J. Clin. Microbiol. 44:4553-4558.
10. García-Cobos, S., J. Campos, E. Lázaro, F. Román, E. Cercenado, C. García-Rey, M. Pérez-Vázquez, J. Oteo, and F. de Abajo. 2007. Ampicillin-resistant non-β-lactamase-producing Haemophilus influenzae in Spain: recent emergence of clonal isolates with increased resistance to cefotaxime and cefixime. Antimicrob. Agents Chemother. 51:2564-2573.
11. Georgiou, M., R. Munoz, F. Roman, R. Canton, R. Gomez-Lus, J. Campos, and A. G. De La Campa. 1996. Ciprofloxacin-resistant Haemophilus influenzae strains possess mutations in analogous positions of GyrA and ParC. Antimicrob. Agents Chemother. 40:1741-1744.
12. Hasegawa, K., K. Yamamoto, N. Chiba, R. Kobayashi, K. Nagai, M. R. Jacobs, P. C. Appelbaum, K. Sunakawa, and K. Ubukata. 2003. Diversity of ampicillin-resistance genes in Haemophilus influenzae in Japan and the United States. Microb. Drug Resist. 9:39-46.
13. Hasegawa, K., R. Kobayashi, E. Takada, A. Ono, N. Chiba, M. Morozumi, S. Iwata, K. Sunakawa, and K. Ubukata. 2006. High prevalence of type b β-lactamase-non-producing ampicillin-resistant Haemophilus influenzae in meningitis: the situation in Japan where Hib vaccine has not been introduced. J. Antimicrob. Chemother. 57:1077-1082.
14. Hoban, D. J., G. V. Doern, A. C. Fluit, M. Roussel-Delvallez, and R. N. Jones. 2001. Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin. Infect. Dis. 32(Suppl. 2):S81-S93.
15. Hotomi, M., K. Fujihara, D. S. Billal, K. Suzuki, T. Nishimura, S. Baba, and N. Yamanaka. 2007. Genetic characteristics and clonal dissemination of β-lactamase-negative ampicillin-resistant Haemophilus influenzae strains isolated from the upper respiratory tract of patients in Japan. Antimicrob. Agents Chemother. 51:3969-3976.
16. Inoue, M., N. Y. Lee, S. W. Hong, K. Lee, and D. Felmingham. 2004. PROTEKT 1999-2000: a multicentre study of the antibiotic susceptibility of respiratory tract pathogens in Hong Kong, Japan and South Korea. Int. J. Antimicrob. Agents 23:44-51.
17. Inoue, M., S. Kohno, M. Kaku, K. Yamaguchi, J. Igari, and K. Yamanaka. 2005. PROTEKT 1999-2000: a multicentre study of the antimicrobial susceptibility of respiratory tract pathogens in Japan. Int. J. Infect. Dis. 9:27-36.
18. Jansen, W. T., A. Verel, M. Beitsma, J. Verhoef, and D. Milatovic. 2006. Longitudinal European surveillance study of antibiotic resistance of Haemophilus influenzae. J. Antimicrob. Chemother. 58:873-877.
19. Karlowsky, J. A., I. A. Critchley, R. S. Blosser-Middleton, E. A. Karginova, M. E. Jones, C. Thornsberry, and D. F. Sahm. 2002. Antimicrobial surveillance of Haemophilus influenzae in the United States during 2000-2001 leads to detection of clonal dissemination of a β-lactamase-negative and ampicillin-resistant strain. J. Clin. Microbiol. 40:1063-1066.
20. Khan, W., S. Ross, W. Rodriguez, G. Controni, and A. K. Saz. 1974. Haemophilus influenzae type b resistant to ampicillin: a report of two cases. JAMA 229:298-301.
21. Kim, I.-S., C.-S. Ki, S. Kim, W. S. Oh, and K. Ran. 2007. Diversity of ampicillin resistance genes and antimicrobial susceptibility patterns in Haemophilus influenzae strains isolated in Korea. Antimicrob. Agents Chemother. 51:453-460.
22. Li, X., N. Mariano, J. J. Rahal, C. M. Urban, and K. Drlica. 2004. Quinolone-resistant Haemophilus influenzae in a long-term-care facility: nucleotide sequence characterization of alterations in the genes encoding DNA gyrase and DNA topoisomerase IV. Antimicrob. Agents Chemother. 48: 3570-3572.
23. Markowitz, S. M. 1980. Isolation of an ampicillin-resistant, non-β-lactamase-producing strain of Haemophilus influenzae. Antimicrob. Agents Chemother. 17:80-83.
24. Morikawa, Y., M. Kitazato, J. Mitsuyama, S. Mizunaga, S. Minami, and Y. Watanabe. 2004. In vitro activities of piperacillin against β-lactamase- negative ampicillin-resistant Haemophilus influenzae. Antimicrob. Agents Chemother. 48:1229-1234.
25. Nazir, J., C. Urban, N. Mariano, J. Burns, B. Tommasulo, C. Rosenberg, S. Segal-Maurer, and J. J. Rahal. 2004. Quinolone-resistant Haemophilus influenzae in a long-term care facility: clinical and molecular epidemiology. Clin. Infect. Dis. 38:1564-1569.
26. Pérez-Vázquez, M., F. Román, B. Aracil, R. Cantón, and J. Campos. 2004. Laboratory detection of Haemophilus influenzae with decreased susceptibility to nalidixic acid, ciprofloxacin, levofloxacin, and moxifloxacin due to gyrA and parC mutations. J. Clin. Microbiol. 42:1185-1191. (Pubitemid 38332845)
27. Pérez-Vázquez, M., F. Román, S. García-Cobos, and J. Campos. 2007. Fluoroquinolone resistance in Haemophilus influenzae is associated with hypermutability. Antimicrob. Agents Chemother. 51:1566-1569.
28. Perichon, B., J. Tankovic, and P. Courvalin. 1997. Characterization of a mutation in the parE gene that confers fluoroquinolone resistance in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 41:1166-1167.
29. Takahashi, H., T. Kikuchi, S. Shoji, S. Fujimura, A. B. Lutfor, Y. Tokue, T. Nukiwa, and A. Watanabe. 1998. Characterization of gyrA, gyrB, grlA and grlB mutations in fluoroquinolone-resistant clinical isolates of Staphylococcus aureus. J. Antimicrob. Chemother. 41:49-57. (Pubitemid 28064250)
30. Tomeh, M. O., S. E. Starr, J. E. McGowan, Jr., P. M. Terry, and A. G. Nahmias. 1974. Ampicillin-resistant Haemophilus influenzae type b infection. JAMA 229:295-297.
31. Ubukata, K., Y. Shibasaki, K. Yamamota, N. Chiba, K. Hasegawa, Y. Takeuchi, K. Sunakawa, M. Inoue, and M. Konno. 2001. Association of amino acid substitutions in penicillin binding protein 3 with β-lactam resistance in β-lactamase- negative ampicillin-resistant Haemophilus influenzae. Antimicrob. Agents Chemother. 45:1693-1699. (Pubitemid 32466336)
32. Yokota, S.-I., Y. Ohkoshi, K. Sato, and N. Fujii. 2008. Emergence of fluoroquinolone- resistant Haemophilus influenzae strains among elderly patients but not among children. J. Clin. Microbiol. 46:361-365.
33. Yoshizumi, S., Y. Takahashi, Y. Watanabe, E. Okezaki, Y. Ishii, and K. Tateda. 2004. In vitro antibacterial activities of new fluoroquinolones against clinical isolates of Haemophilus influenzae with ciprofloxacin-resistance- associated alterations in GyrA and ParC. Chemotherapy 50:265-275.